Simon Dumesnil Pasithea Therapeutics Corp. (KTTA) insider trading activity
Simon Dumesnil is Director of Pasithea Therapeutics Corp.. Currently has a direct ownership of 50,000 shares of KTTA, which is worth approximately $129,000. The most recent transaction as insider was on Nov 17, 2022, when has been sold 40,000 shares (Common Stock) at a price of $1.06 per share, resulting in proceeds of $42,400. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
50K
0%
3M change
0%
12M change
Total Value Held
$129,000
Simon Dumesnil Transaction History
SD
Simon Dumesnil
Director
Miami Beach, FL